Use of hydroxychloroquine in multidrug protocols for SARS-CoV-2

We review the available evidence supporting the use of hydroxychloroquine-based multidrug protocols in the treatment of COVID-19, in response to a recently published editorial in the Tasman Medical Journal.

Publication Details

Journal
Figshare
Published
2024-09-19
DOI
https://doi.org/10.6084/m9.figshare.27058816
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of hydroxychloroquine in multidrug protocols for SARS-CoV-2

Figshare
COVID-19 Clinical Research Studies
article

Use of hydroxychloroquine in multidrug protocols for SARS-CoV-2

article en

Abstract

We review the available evidence supporting the use of hydroxychloroquine-based multidrug protocols in the treatment of COVID-19, in response to a recently published editorial in the Tasman Medical Journal.

Figshare
Good health and well-being
Openalex Percentile: Top 59%
COVID-19 Clinical Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Use of hydroxychloroquine in multidrug protocols for SARS-CoV-2 · Figshare (2024) | TGRS Research Map | TGRS